Ipca Laboratories Limited (NSE:IPCALAB)

Ipca Laboratories Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Operating Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Income	11,411	7,377	5,474	4,713	8,841
Depreciation & Amortization	4,097	3,913	3,494	2,539	2,257
Other Amortization	84.5	64.8	78.4	76.3	67.4
Loss (Gain) From Sale of Assets	-3,406	-27.6	-38.5	-160.5	0.3
Asset Writedown & Restructuring Costs	115.7	1,168	9.3	28.4	113.6
Loss (Gain) From Sale of Investments	289.4	1,504	-614.5	13.8	-27.8
Stock-Based Compensation	8.1	20.6	30.6	-	-
Provision & Write-off of Bad Debts	79.9	38	8.3	22.7	11.6
Other Operating Activities	1,680	919	1,921	335	25.2
Change in Accounts Receivable	-489.1	-2,177	-758	-681	-802.4
Change in Inventory	-1,706	-915.6	-947	1,146	-2,492
Change in Accounts Payable	667.7	726.6	214.9	-324	-1,097
Change in Other Net Operating Assets	-1,412	601.1	574.2	348.9	1,664
Operating Cash Flow	11,420	13,213	9,447	8,058	8,561
Operating Cash Flow Growth	-13.57%	39.87%	17.23%	-5.87%	-21.47%

Investing Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Capital Expenditures	-6,560	-7,756	-4,113	-4,945	-4,790
Sale of Property, Plant & Equipment	3,390	53.3	86.2	361.5	28.4
Cash Acquisitions	-	-	-15,429	-105.9	-301.1
Investment in Securities	35.3	-334.5	396.7	-453.4	-3,917
Other Investing Activities	735.4	-658.1	6,121	-2,177	429.1
Investing Cash Flow	-2,468	-8,695	-12,918	-7,250	-8,551

Financing Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Short-Term Debt Issued	-	-	-	2,943	1,933
Long-Term Debt Issued	-	2,184	1,237	3,917	4,137
Total Debt Issued	-	2,184	1,237	6,860	6,070
Short-Term Debt Repaid	-777.6	-639.4	-3,038	-	-
Long-Term Debt Repaid	-5,418	-2,616	-1,874	-357.6	-726
Total Debt Repaid	-6,195	-3,255	-4,913	-357.6	-726
Net Debt Issued (Repaid)	-6,195	-1,072	-3,676	6,502	5,344
Common Dividends Paid	-524.1	-1,015	-507.4	-1,015	-1,015
Other Financing Activities	-815.8	-743.5	-1,343	-414.8	-61.8
Financing Cash Flow	-7,535	-2,830	-5,526	5,072	4,268

Net Cash Flow

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Miscellaneous Cash Flow Adjustments	-	-	765	-	41.2
Net Cash Flow	1,417	1,688	-8,232	5,881	4,319

Free Cash Flow

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Free Cash Flow	4,860	5,458	5,334	3,113	3,771
Free Cash Flow Growth	-10.95%	2.32%	71.31%	-17.44%	-48.24%
Free Cash Flow Margin	5.04%	6.10%	6.92%	4.98%	6.47%
Free Cash Flow Per Share	19.16	21.51	21.02	12.27	14.87
Levered Free Cash Flow	7,901	215.43	-6,829	1,904	1,448
Unlevered Free Cash Flow	8,375	742.43	-5,971	2,186	1,493

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash Interest Paid	815.8	743.5	1,343	414.8	61.8
Cash Income Tax Paid	4,140	3,613	2,963	2,237	2,020
Change in Working Capital	-2,940	-1,765	-915.9	489.9	-2,727

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 30, 2026

Data Sources Report a data error